Thyroid Nodules

smart doctor on

 Thyroid Nodules  

1. Definition & Epidemiology

  • Thyroid nodules = abnormal growths (lumps) within the thyroid gland.

  • Very common:

    • Seen in ~50% of the population (detected by imaging or autopsy).

    • Only 5–10% are palpable on exam.

  • More common in women and in iodine-deficient areas.

  • Incidence increases with age.

👉 Key point: Most thyroid nodules are harmless, but a small proportion are cancers — so evaluation is important.

2. Etiology

  • Benign nodules (~95%)

    • Colloid cysts

    • Follicular adenomas

    • Nodules from Hashimoto thyroiditis

  • Malignant nodules (~5%)

    • Most common: papillary thyroid carcinoma

    • Less common: follicular, medullary, anaplastic

👉 Red flags (risk factors for malignancy):

  • Male sex

  • Prior head/neck radiation exposure

  • Family history of MEN2 or differentiated thyroid cancer

  • Suspicious ultrasound features (solid, irregular, microcalcifications)

  • Cold nodules on radioiodine scans

3. Incidental Nodules

  • Thyroid incidentaloma = nodule discovered accidentally during imaging for another reason (e.g., CT, carotid Doppler).

  • Must be evaluated just like any other thyroid nodule.

4. Diagnostic Approach

Step 1: Initial tests (for all nodules)

  1. TSH assay

    • High/normal TSH → proceed with ultrasound ± FNAC.

    • Low TSH → do a radioiodine uptake scan first.

  2. Thyroid ultrasound

    • To assess size, structure, solid vs cystic, suspicious features.

    • Ultrasound guides decision for fine-needle aspiration cytology (FNAC).

Step 2: FNAC (Fine-Needle Aspiration Cytology)

  • Indications: nodules with suspicious sonographic features.

  • Purpose: to detect malignancy.

  • Problem: FNAC cannot distinguish follicular adenoma from follicular carcinoma → further testing (molecular tests or surgical excision) needed.

Step 3: Thyroid scintigraphy (radioiodine scan)

  • Performed if TSH is low (suggesting hyperthyroidism).

  • Categorizes nodules as:

    • Hot (autonomous) → increased iodine uptake; usually benign; do NOT need FNAC.

    • Cold (nonfunctioning) → decreased uptake; 5–15% risk of cancer → need FNAC if suspicious.

👉 Clinical significance: hot nodules are usually toxic adenomas or part of toxic multinodular goiter, while cold nodules are more worrisome for cancer.

5. Specific Types of Nodules

A. Follicular Adenoma

  • Benign tumor of thyroid follicular cells.

  • Presentation: usually a slow-growing, solitary nodule.

  • Diagnosis: FNAC suggests “follicular neoplasm,” but definitive diagnosis requires histopathology (no invasion through capsule or vessels).

B. Toxic Adenoma

  • Pathophysiology: Mutation in the TSH receptor gene → autonomous hormone production from a single nodule.

  • Result: hyperthyroidism (thyrotoxicosis).

  • Diagnosis: radioiodine scan shows a single hot nodule with suppressed uptake in the rest of the gland.

C. Toxic Multinodular Goiter (MNG)

  • Pathophysiology: Long-standing multinodular goiter develops mutations → multiple nodules become autonomous.

  • Clinical features: goiter with multiple palpable nodules + hyperthyroidism.

  • Diagnosis:

    • Radioiodine scan: multiple hot nodules.

    • Histology: enlarged follicles with colloid, flattened epithelium.

6. Management

  • Malignant nodules → surgery (thyroidectomy ± lymph node dissection).

  • Autonomous/hot nodules → surgery or radioiodine ablation.

  • Thyroid cysts → aspiration.

  • Small, benign nodules → monitoring with ultrasound.

✅ Summary Table

Feature Benign (~95%) Malignant (~5%)
Examples Colloid cyst, follicular adenoma, Hashimoto Papillary (most common), follicular, medullary, anaplastic
Risk Low Higher if male, radiation, family history, cold nodule
Scan Often cold or hot benign lesions Usually cold
FNAC Confirms benign; but follicular tumors need excision to rule out cancer Confirms cancer (except follicular carcinoma, needs histology)

⚡ Key takeaway:
Most thyroid nodules are benign and require only observation. The real concern is identifying malignant or autonomous nodules, which is done through a systematic approach: TSH → ultrasound → FNAC/scintigraphy → management.


Comments

Post a Comment